Anesthesia — Therapeutic Area Intelligence | Humanexa Signals

ClinicalAugust 4, 2026

Evaluating Perineural Catheter for Postoperative Pain in Hindfoot Surgery

A study is assessing the efficacy of perineural catheters versus single nerve blocks for postoperative pain management in hindfoot surgery.

RegulatoryAugust 3, 2026

FDA Accepts Supplement for Dexmedetomidine Hydrochloride NDA 206628

The FDA has accepted a supplemental application for Dexmedetomidine Hydrochloride under NDA 206628.

RegulatoryAugust 2, 2026

FDA grants supplemental approval for PRECEDEX (dexmedetomidine hydrochloride)

The FDA has granted supplemental approval for PRECEDEX, a sedative agent, under NDA021038.

ClinicalAugust 1, 2026

Dexmedetomidine Administration Routes Impact Postoperative Sleep in Thyroidectomy Patients

This study investigates the effects of intranasal versus intravenous dexmedetomidine on sleep quality after thyroid surgery.

RegulatoryAugust 1, 2026

Hikma's Sugammadex Sodium ANDA218727 Receives Approval Status

Hikma's ANDA for Sugammadex Sodium has received an approval status (AP) from the FDA.

CompetitiveAugust 1, 2026

Hikma's Sugammadex Sodium ANDA218728 Receives Abbreviated Approval

Hikma's ANDA218728 for Sugammadex Sodium has received Abbreviated Approval from the FDA.

StrategyAugust 1, 2026

FDA Grants Approval for Sugammadex Sodium (ANDA218814) by SteriScience

The FDA has granted approval for Sugammadex Sodium under application ANDA218814 submitted by SteriScience.

RegulatoryAugust 1, 2026

Teva's Sugammadex Sodium Receives FDA Approval Status

Teva Pharmaceuticals has received an Abbreviated New Drug Application (ANDA) approval status for Sugammadex Sodium.

StrategyAugust 1, 2026

FDA Grants Approval for Sugammadex Sodium ANDA219448 by Fresenius Kabi

The FDA has granted approval for the ANDA219448 application for Sugammadex Sodium submitted by Fresenius Kabi.

RegulatoryAugust 1, 2026

FDA Accepts Sugammadex Sodium Application from Mankind Pharma

The FDA has accepted the application for Sugammadex Sodium submitted by Mankind Pharma.

CompetitiveAugust 1, 2026

Dr. Reddy's Sugammadex Sodium ANDA214236 Receives FDA Approval

Reddy's has received FDA approval for Sugammadex Sodium under ANDA214236.

RegulatoryAugust 1, 2026

FDA Grants Approval for Sugammadex Sodium ANDA214306 by Zenara

The FDA has granted approval for the ANDA214306 application for Sugammadex Sodium submitted by Zenara.

StrategyAugust 1, 2026

Sandoz Receives FDA Approval for Sugammadex Sodium (ANDA214311)

Sandoz has received an Abbreviated New Drug Application (ANDA) approval for Sugammadex Sodium.

CompetitiveAugust 1, 2026

FDA Grants Approval for Sugammadex Sodium ANDA214319 by Sun Pharma

The FDA has granted approval for Sugammadex Sodium under application ANDA214319 submitted by Sun Pharma.

RegulatoryAugust 1, 2026

Mylan's Sugammadex Sodium ANDA213915 Receives AP Status from FDA

Mylan's ANDA for Sugammadex Sodium has received an Abbreviated Approval (AP) status from the FDA.

RegulatoryAugust 1, 2026

Lupin's Sugammadex Sodium ANDA214338 Receives Approval Status

Lupin's ANDA214338 for Sugammadex Sodium has received an approval status of AP from the FDA.

RegulatoryAugust 1, 2026

FDA Approves Sugammadex Sodium for Gland Pharma

The FDA has approved Sugammadex Sodium under application ANDA214364 submitted by Gland Pharma.

RegulatoryAugust 1, 2026

FDA Grants Approval for Sugammadex Sodium under ANDA214368

The FDA has granted approval for Sugammadex Sodium under ANDA214368, submitted by MSN.

ClinicalJuly 29, 2026

Study Compares Systemic Lidocaine to Adductor Canal Block in Knee Surgery

This study evaluates postoperative outcomes in total knee arthroplasty patients receiving systemic lidocaine versus an adductor canal block.

ClinicalJuly 29, 2026

Study on Oxygenation Strategies for Obese Patients During Intubation

A clinical trial is comparing two oxygenation strategies for obese patients undergoing intubation: NIV with HFNO versus NIV alone.

RegulatoryJuly 28, 2026

FDA Grants Approval for Bupivacaine Hydrochloride by Anthea Pharma

The FDA has granted approval for Bupivacaine Hydrochloride under application ANDA220493 submitted by Anthea Pharma.

RegulatoryJuly 27, 2026

FDA Grants Approval for Dexmedetomidine Hydrochloride by Baxter Healthcare

The FDA has granted approval for Dexmedetomidine Hydrochloride under application ANDA208103 submitted by Baxter Healthcare.

RegulatoryJuly 23, 2026

Zydus Pharms receives AP status for Dexmedetomidine Hydrochloride ANDA206798

Zydus Pharms has received an Abbreviated New Drug Application (ANDA) approval status for Dexmedetomidine Hydrochloride.

ClinicalJuly 20, 2026

Study on PVI Predictors in Laparoscopic Hysterectomy to Enhance Fluid Management

The study investigates predictors of Pleth Variability Index changes during laparoscopic hysterectomy, focusing on intraoperative positional shifts.

ClinicalJuly 20, 2026

Study on Retrolaminar Block's Impact on Opioid Use in Spine Surgery

A randomized controlled trial is evaluating the effectiveness of retrolaminar block in reducing opioid consumption post-lumbar spine fusion.

ClinicalJuly 19, 2026

Trial Evaluates Superficial Cervical Block to Reduce Opioid Use in Cervical Discectomy

A randomized controlled trial is assessing the impact of superficial cervical block on opioid consumption post-anterior cervical discectomy.

RegulatoryJuly 18, 2026

FDA Accepts Supplement Application for Rocuronium Bromide by Fresenius Kabi

The FDA has accepted a supplemental application for Rocuronium Bromide submitted by Fresenius Kabi.

StrategyJuly 18, 2026

FDA Grants Approval for Propofol ANDA220857 by Anthea Pharma

The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 220857 for Propofol submitted by Anthea Pharma.

RegulatoryJuly 17, 2026

B. Braun Medical Recalls Spinal Anesthesia Kits Due to Bupivacaine Hydrochloride Issues

Braun Medical is recalling convenience kits that contain Bupivacaine Hydrochloride in Dextrose Injection due to safety concerns.

RegulatoryJuly 14, 2026

FDA Submission Update for Sugammadex by Tamarang SA

Tamarang SA has submitted an original ANDA for Sugammadex, currently under standard review.

ClinicalJuly 13, 2026

Trial on Low-Dose Remimazolam for Emergence Agitation in Oral Surgery

A randomized controlled trial is set to evaluate the impact of low-dose remimazolam on emergence agitation in oral surgery.

ClinicalJuly 12, 2026

Study on Erector Spinae Plane Block for Pain Control in Spinal Surgery

A clinical trial is evaluating the efficacy of ultrasound-guided erector spinae plane block in major spinal surgery.

RegulatoryJuly 12, 2026

FDA Accepts Supplemental NDA for Dexmedetomidine Hydrochloride

The FDA has accepted a supplemental NDA for Dexmedetomidine Hydrochloride submitted by HQ SPCLT PHARMA.

RegulatoryJuly 12, 2026

FDA Accepts Supplement for PRECEDEX (Dexmedetomidine Hydrochloride)

The FDA has accepted a supplemental application for PRECEDEX, indicating ongoing development and potential label updates.

ClinicalJuly 11, 2026

Study on Vibratory Anesthesia for Pain Management in Corticosteroid Injections

A study is evaluating the effectiveness of vibratory and vapo-coolant anesthesia compared to no anesthesia during corticosteroid injections.

RegulatoryJuly 9, 2026

FDA Approval Status Update for Remifentanil Hydrochloride by Fresenius Kabi

Fresenius Kabi USA has submitted a supplemental application for Remifentanil Hydrochloride, currently under standard review.

RegulatoryJuly 8, 2026

FDA Grants AP Status for Sufentanil Citrate ANDA074534 by Hospira

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Sufentanil Citrate submitted by Hospira.

ClinicalJuly 6, 2026

Study on Dexmedetomidine vs Magnesium Sulphate for Thoracotomy Pain Management

The study compares the efficacy of dexmedetomidine and magnesium sulphate as adjuvants in erector spinae block for thoracotomy pain.

RegulatoryJuly 5, 2026

Anthea Pharma's Bupivacaine Hydrochloride ANDA220493 Receives AP Status

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Bupivacaine Hydrochloride submitted by Anthea Pharma.

RegulatoryJuly 4, 2026

Baxter Healthcare's Dexmedetomidine Hydrochloride ANDA208103 Receives AP Status

Baxter Healthcare Corporation's application for Dexmedetomidine Hydrochloride has received an Abbreviated Approval (AP) status from the FDA.

ClinicalJuly 4, 2026

Esketamine Improves Postoperative Emotions and Immune Function in Acoustic Neuroma Surgery

A randomized clinical trial found that sub-anesthetic doses of esketamine may enhance immune function and reduce negative emotions post-surgery in acoustic neuroma patients.

RegulatoryJuly 3, 2026

FDA Investigates Neurologic Risks of General Anesthesia Linked to Genetic Variant

The FDA is investigating severe neurologic complications associated with general anesthesia in patients of Venezuelan ancestry.

ClinicalJuly 1, 2026

Dexmedetomidine-esketamine combo may reduce delirium in ICU patients

A clinical trial is investigating the efficacy of a dexmedetomidine-esketamine combination to reduce delirium in ICU patients.

RegulatoryJuly 1, 2026

FDA Grants AP Status for Lidocaine Hydrochloride ANDA040078

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Lidocaine Hydrochloride submitted by Hospira.

ClinicalJune 27, 2026

Study on Ketamine vs Fentanyl for Pain Management in Laparoscopic Cholecystectomy

A randomized double-blind study is comparing intraperitoneal ketamine and fentanyl as adjuvants to bupivacaine for postoperative pain control in laparoscopic cholecystectomy.

ClinicalJune 26, 2026

Trial Comparing S-ESP vs FICB for Postoperative Pain Relief After Hip Arthroplasty

This trial aims to evaluate the analgesic efficacy of continuous S-ESP block compared to FICB in hip arthroplasty patients.

ClinicalJune 25, 2026

Oliceridine shows potential to reduce PONV in thyroid surgery compared to sufentanil

A study comparing oliceridine to sufentanil in thyroid surgery suggests oliceridine may reduce postoperative nausea and vomiting.

ClinicalJune 25, 2026

Study on Ketamine's Impact on Anaesthesia Depth Consistency in Laparoscopic Surgery

A randomized controlled study is set to evaluate the effect of subanaesthetic ketamine on anaesthesia depth consistency during laparoscopic surgery using automated propofol TIVA.

ClinicalJune 25, 2026

Study on Bupivacaine Dilution Impact in Infraclavicular Block Outcomes

This study compares the effects of D5W versus saline as a diluent for bupivacaine in infraclavicular blocks.

StrategyJune 23, 2026

FDA Grants AP Status for Succinylcholine Chloride ANDA217873

The FDA has granted approval status (AP) for ANDA217873, a generic formulation of Succinylcholine Chloride by STERISCIENCE.

ClinicalJune 22, 2026

Opioid Free Anesthesia Strategy May Improve Outcomes in AAA Repair

A trial is investigating an Opioid Free Anesthesia-Analgesia strategy for elective open abdominal aortic aneurysm repair, hypothesizing improved patient outcomes.

StrategyJune 22, 2026

Medline Issues Correction for Bupivacaine Hydrochloride Kits

Medline is recalling convenience kits that contain Huons Bupivacaine Hydrochloride in Dextrose Injection due to safety concerns.

ClinicalJune 21, 2026

Study on Transnasal Microstream EtCO2 Monitoring in Elderly Post-Surgery Patients

A randomized controlled trial is assessing the impact of transnasal microstream EtCO₂ monitoring on hypoxemia in elderly patients post-abdominal surgery.

CompetitiveJune 20, 2026

Draeger Issues Correction for A350 and A350XL Anesthesia Machines Due to Ventilator Failure Risk

Draeger, Inc. is correcting additional anesthesia workstations due to a manufacturing error that may lead to ventilator failure.

ClinicalJune 2, 2026

Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction

This clinical trial aims to compare the analgesic efficacy of Serratus Posterior Superior Intercostal Plane Block and Thoracic Paravertebral Block in reducing postoperative opioid consumption after open thoracotomy.

Companies

Assets

Recent signals(55)

Evaluating Perineural Catheter for Postoperative Pain in Hindfoot Surgery

FDA Accepts Supplement for Dexmedetomidine Hydrochloride NDA 206628

FDA grants supplemental approval for PRECEDEX (dexmedetomidine hydrochloride)

Dexmedetomidine Administration Routes Impact Postoperative Sleep in Thyroidectomy Patients

Hikma's Sugammadex Sodium ANDA218727 Receives Approval Status

Hikma's Sugammadex Sodium ANDA218728 Receives Abbreviated Approval

FDA Grants Approval for Sugammadex Sodium (ANDA218814) by SteriScience

Teva's Sugammadex Sodium Receives FDA Approval Status

FDA Grants Approval for Sugammadex Sodium ANDA219448 by Fresenius Kabi

FDA Accepts Sugammadex Sodium Application from Mankind Pharma

Dr. Reddy's Sugammadex Sodium ANDA214236 Receives FDA Approval

FDA Grants Approval for Sugammadex Sodium ANDA214306 by Zenara

Sandoz Receives FDA Approval for Sugammadex Sodium (ANDA214311)

FDA Grants Approval for Sugammadex Sodium ANDA214319 by Sun Pharma

Mylan's Sugammadex Sodium ANDA213915 Receives AP Status from FDA

Lupin's Sugammadex Sodium ANDA214338 Receives Approval Status

FDA Approves Sugammadex Sodium for Gland Pharma

FDA Grants Approval for Sugammadex Sodium under ANDA214368

Study Compares Systemic Lidocaine to Adductor Canal Block in Knee Surgery

Study on Oxygenation Strategies for Obese Patients During Intubation

FDA Grants Approval for Bupivacaine Hydrochloride by Anthea Pharma

FDA Grants Approval for Dexmedetomidine Hydrochloride by Baxter Healthcare

Zydus Pharms receives AP status for Dexmedetomidine Hydrochloride ANDA206798

Study on PVI Predictors in Laparoscopic Hysterectomy to Enhance Fluid Management

Study on Retrolaminar Block's Impact on Opioid Use in Spine Surgery

Trial Evaluates Superficial Cervical Block to Reduce Opioid Use in Cervical Discectomy

FDA Accepts Supplement Application for Rocuronium Bromide by Fresenius Kabi

FDA Grants Approval for Propofol ANDA220857 by Anthea Pharma

B. Braun Medical Recalls Spinal Anesthesia Kits Due to Bupivacaine Hydrochloride Issues

FDA Submission Update for Sugammadex by Tamarang SA

Trial on Low-Dose Remimazolam for Emergence Agitation in Oral Surgery

Study on Erector Spinae Plane Block for Pain Control in Spinal Surgery

FDA Accepts Supplemental NDA for Dexmedetomidine Hydrochloride

FDA Accepts Supplement for PRECEDEX (Dexmedetomidine Hydrochloride)

Study on Vibratory Anesthesia for Pain Management in Corticosteroid Injections

FDA Approval Status Update for Remifentanil Hydrochloride by Fresenius Kabi

FDA Grants AP Status for Sufentanil Citrate ANDA074534 by Hospira

Study on Dexmedetomidine vs Magnesium Sulphate for Thoracotomy Pain Management

Anthea Pharma's Bupivacaine Hydrochloride ANDA220493 Receives AP Status

Baxter Healthcare's Dexmedetomidine Hydrochloride ANDA208103 Receives AP Status

Esketamine Improves Postoperative Emotions and Immune Function in Acoustic Neuroma Surgery

FDA Investigates Neurologic Risks of General Anesthesia Linked to Genetic Variant

Dexmedetomidine-esketamine combo may reduce delirium in ICU patients

FDA Grants AP Status for Lidocaine Hydrochloride ANDA040078

Study on Ketamine vs Fentanyl for Pain Management in Laparoscopic Cholecystectomy

Trial Comparing S-ESP vs FICB for Postoperative Pain Relief After Hip Arthroplasty

Oliceridine shows potential to reduce PONV in thyroid surgery compared to sufentanil

Study on Ketamine's Impact on Anaesthesia Depth Consistency in Laparoscopic Surgery

Study on Bupivacaine Dilution Impact in Infraclavicular Block Outcomes

FDA Grants AP Status for Succinylcholine Chloride ANDA217873

Opioid Free Anesthesia Strategy May Improve Outcomes in AAA Repair

Medline Issues Correction for Bupivacaine Hydrochloride Kits

Study on Transnasal Microstream EtCO2 Monitoring in Elderly Post-Surgery Patients

Draeger Issues Correction for A350 and A350XL Anesthesia Machines Due to Ventilator Failure Risk

Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction

Upcoming catalysts

Indications

Get signals before the market moves